Pharmacogenomics and Pharmacoproteomics

Pharmacogenomics & Pharmacoproteomics is the study of the role of genetics in drug response and provided DNA for genomes. It deals with the influence of acquired and inherited genetic variation on drug response in patients by Protein aggregation and stability in biopharmaceuticals, New discoveries in genomic targets, Various drug responses due to genetic polymorphisms, Drug dosage formulations, Drug safety and its efficacy and Membrane transport proteins. There are almost 3000 people from 60-65 universities in USA working for Proteomics. The NIH Pharmacogenomics Research Network (PGRN) is a network of scientists funding to PharmGKB since 2000.

  • Protein aggregation and stability in biopharmaceuticals
  • New discoveries in genomic targets
  • Various drug responses due to genetic polymorphisms
  • Drug dosage formulations
  • Drug safety and its efficacy
  • Membrane transport proteins

Related Conference of Pharmacogenomics and Pharmacoproteomics

Pharmacogenomics and Pharmacoproteomics Conference Speakers